Copying and distributing are prohibited without permission of the publisher.


Biostime brushes off melamine scandal with European production lines to price mid range

09 Dec 2010

Biostime International Holdings, the pediatric nutrition and baby care product producer, braved a volatile Hong Kong market this week to successfully price a HK$1.7bn ($212m) IPO in the middle of its price range.

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free Trial
09 Dec 2010